rs4986996
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 6P and 4B. PM1PP3_StrongBS2
The NM_000015.3(NAT2):c.364G>A(p.Asp122Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,612,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D122G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000015.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151980Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.000112 AC: 28AN: 249562 AF XY: 0.000104 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460490Hom.: 0 Cov.: 58 AF XY: 0.0000275 AC XY: 20AN XY: 726546 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151980Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74210 show subpopulations
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at